Brain Financial Statements From 2010 to 2025

BRSF Stock  USD 0.75  0.00  0.00%   
Brain Scientific financial statements provide useful quarterly and yearly information to potential Brain Scientific investors about the company's current and past financial position, as well as its overall management performance and changes in financial position over time. Historical trend examination of various income statement and balance sheet accounts found on Brain Scientific financial statements helps investors assess Brain Scientific's valuation, profitability, and current liquidity needs. Key fundamental drivers impacting Brain Scientific's valuation are summarized below:
Brain Scientific does not presently have any fundamental signals for analysis.
Check Brain Scientific financial statements over time to gain insight into future company performance. You can evaluate financial statements to find patterns among Brain Scientific's main balance sheet or income statement drivers, such as , as well as many indicators such as . Brain financial statements analysis is a perfect complement when working with Brain Scientific Valuation or Volatility modules.
  
This module can also supplement various Brain Scientific Technical models . Check out the analysis of Brain Scientific Correlation against competitors.

Brain Scientific Company Current Valuation Analysis

Brain Scientific's Enterprise Value is a firm valuation proxy that approximates the current market value of a company. It is typically used to determine the takeover or merger price of a firm. Unlike Market Cap, this measure takes into account the entire liquid asset, outstanding debt, and exotic equity instruments that the company has on its balance sheet. When a takeover occurs, the parent company will have to assume the target company's liabilities but will take possession of all cash and cash equivalents.

Enterprise Value

 = 

Market Cap + Debt

-

Cash

More About Current Valuation | All Equity Analysis

Current Brain Scientific Current Valuation

    
  12.28 M  
Most of Brain Scientific's fundamental indicators, such as Current Valuation, are part of a valuation analysis module that helps investors searching for stocks that are currently trading at higher or lower prices than their real value. If the real value is higher than the market price, Brain Scientific is considered to be undervalued, and we provide a buy recommendation. Otherwise, we render a sell signal.
Enterprise Value can be a useful tool to compare companies with different capital structures. Long term liability and current cash or cash equivalents can have a huge impact on market valuation of a given company.
Competition

In accordance with the recently published financial statements, Brain Scientific has a Current Valuation of 12.28 M. This is 99.91% lower than that of the Healthcare sector and 99.9% lower than that of the Medical Devices industry. The current valuation for all United States stocks is 99.93% higher than that of the company.

Brain Scientific Fundamental Drivers Relationships

Comparative valuation techniques use various fundamental indicators to help in determining Brain Scientific's current stock value. Our valuation model uses many indicators to compare Brain Scientific value to that of its competitors to determine the firm's financial worth. You can analyze the relationship between different fundamental ratios across Brain Scientific competition to find correlations between indicators driving Brain Scientific's intrinsic value. More Info.
Brain Scientific is rated second in return on equity category among its peers. It is rated third in return on asset category among its peers . The reason why the comparable model can be used in almost all circumstances is due to the vast number of multiples that can be utilized, such as the price-to-earnings (P/E), price-to-book (P/B), price-to-sales (P/S), price-to-cash flow (P/CF), and many others. The P/E ratio is the most commonly used of these ratios because it focuses on the Brain Scientific's earnings, one of the primary drivers of an investment's value.

About Brain Scientific Financial Statements

Brain Scientific stakeholders use historical fundamental indicators, such as Brain Scientific's revenue or net income, to determine how well the company is positioned to perform in the future. Although Brain Scientific investors may analyze each financial statement separately, they are all interrelated. For example, changes in Brain Scientific's assets and liabilities are reflected in the revenues and expenses on Brain Scientific's income statement, which ultimately affect the company's gains or losses. Understanding these patterns can help in making the right long-term investment decisions in Brain Scientific. Please read more on our technical analysis and fundamental analysis pages.
Brain Scientific Inc., a medtech company, provides neurology-focused medical devices and electric motors in the United States. Brain Scientific Inc. was founded in 2013 and is headquartered in Sarasota, Florida. Brain Scientific operates under Medical Devices classification in the United States and is traded on OTC Exchange. It employs 28 people.

Currently Active Assets on Macroaxis

Other Information on Investing in Brain Pink Sheet

Brain Scientific financial ratios help investors to determine whether Brain Pink Sheet is cheap or expensive when compared to a particular measure, such as profits or enterprise value. In other words, they help investors to determine the cost of investment in Brain with respect to the benefits of owning Brain Scientific security.